The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis”

  1. Sampayo-Cordero, M.
  2. Miguel-Huguet, B.
  3. Malfettone, A.
  4. Pérez-García, J.M.
  5. Llombart-Cussac, A.
  6. Cortés, J.
  7. Pardo, A.
  8. Pérez-López, J.
Revista:
Frontiers in Molecular Biosciences

ISSN: 2296-889X

Año de publicación: 2021

Volumen: 8

Tipo: Revisión

DOI: 10.3389/FMOLB.2021.690615 GOOGLE SCHOLAR lock_openAcceso abierto editor